Quality problems delay start of controlled cannabis sales in Basel
The «Weed Care» pilot project in the city of Basel was supposed to launch today and understand to supply 370 people with cannabis for 2.5 years. It was put on hold because traces of pesticides were found in some of the supposedly organic plants.
The Basel health department stated that the delay could last several weeks, even months, as the products now need to be re-analyzed by an independent body.
Six products—four types of cannabis flowers and two types of hashish—were supposed to go on sale in nine pharmacies starting this week.

Participants will be able to legally purchase these six products during the pilot project – Credit Pure Holdings AG
The Federal Office of Public Health has approved the pilot project last April as part of a project led by the University of Basel, its psychiatric clinics, and the cantonal health department.
It should allow for the evaluation of effects of the new regulation on recreational cannabis use and, in the long term, to combat black market distribution.
Several other local authorities, including Zurich, Biel, Geneva, and Bern, also put themselves forward as candidates to conduct similar trials. The Swiss Parliament laid the legal groundwork for such small-scale initiatives in September 2020.
The Basel pilot, which will allow 370 people to participate in the sale of approved products, received 700 applications.
The Basel health authorities will now consider options, including other products from the same supplier or other suppliers.
-
Cannabis in Africa1 week ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France1 week ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France1 week ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean1 week ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Cannabinoids1 week ago
Japan bans CBN
-
Business1 week ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Business2 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in the U.S.1 week ago
Trump's reclassification of cannabis is being challenged in court


You must be logged in to post a comment Login